This brand name is authorized in Cyprus, Singapore
The drug FAMOPSIN contains one active pharmaceutical ingredient (API):
1
Famotidine
UNII 5QZO15J2Z8 - FAMOTIDINE
|
Famotidine is a potent competitive H2-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
FAMOPSIN 40mg Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
FAMOPSIN 20mg Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A02BA03 | Famotidine | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BA H2-receptor antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: SG | Health Sciences Authority | Identifier(s): 05640P, 05641P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.